MENU
FULC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Fulcrum Therapeutics (FULC) Earnings Date & Reports
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases... Show more
A.I. Advisor
published Earnings
FULC is expected to report earnings to fall 67.97% to -10 cents per share on October 29
Q3'26
Est.
$-0.11
Q2'26
Missed
by $0.12
Q1'26
Beat
by $0.05
Q4'25
Est.
$-0.31
Q3'25
Missed
by $0.02
The last earnings report on August 13 showed earnings per share of -34 cents, missing the estimate of -22 cents. With 233.79K shares outstanding, the current market capitalization sits at 283.06M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.
Industry Biotechnology
Profile
Details
Industry
N/A
Address
26 Landsdowne Street
Phone
+1 617 651-8851
Employees
55
Web
https://www.fulcrumtx.com